Path to Independence Program

The Path to Independence self-administration training and support program provides hands-on self-administration training and ongoing support, delivered by specially trained infusion nurses, to eligible patients who are receiving therapy with CINRYZE® (C1 esterase inhibitor [human]).

Here's how the program works:

  • A specially trained infusion nurse will visit your home, physician’s office, outpatient infusion clinic, or location of choice (that both you and your doctor agree upon) to:
    • Conduct the necessary training on self-administration
    • Provide instruction on proper reconstitution and self-administration techniques
    • Provide feedback to your doctor after each visit
    • Determine if you are ready to self-administer CINRYZE® (C1 esterase inhibitor [human]) independently
  • The infusion nurse will visit at a time that is convenient for you, including evenings and weekends. All aspects of this program are a complimentary service from the CINRYZESolutions® Programs. There will be no cost to you or impact on your health plan benefits.

Once you have finished self-administration training through the Path to Independence Program, an infusion nurse will visit you periodically during your therapy with CINRYZE.

If you have learned how to self-administer CINRYZE, separate from the program, a Path to Independence infusion nurse will also visit you periodically. These nurses have been specially trained to:

  • Give guidance and feedback on the proper way to reconstitute and infuse CINRYZE
  • Answer any questions you may have about the infusion process
  • Help you stay on track with your CINRYZE® (C1 esterase inhibitor [human]) therapy

Do not attempt to self-administer unless you have been taught how by your healthcare provider.

Connect with an HAE Mentor

Join the CINRYZEConnect Program to connect with a mentor who’s also living with HAE.

Find out more ›

Share Your HAE Knowledge

Spread awareness and help family and friends better understand HAE with the Awareness Kit.

Learn more ›

Indication
CINRYZE® (C1 esterase inhibitor [human]) is an injectable medicine that is used to help prevent swelling and/or painful attacks in teenagers and adults with Hereditary Angioedema (HAE).

Important Risk Information
You should not use CINRYZE if you have had life-threatening immediate hypersensitivity reactions, including anaphylaxis to the product.

Tell your healthcare provider about all of your medical conditions, including if you:

  • have an indwelling catheter/access device in one of your veins.
  • have a history of blood clots, heart disease, or stroke.
  • are taking birth control pills or androgens.
  • are pregnant or planning to become pregnant. It is not known if CINRYZE can harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if CINRYZE passes into your milk and if it can harm your baby.

Tell your healthcare provider and pharmacist about all of the medicines you take, including all prescription and non-prescription medicines such as over-the-counter medicines, supplements, or herbal remedies.

Allergic reactions may occur with CINRYZE. Call your healthcare provider or get emergency support services right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • turning blue (look at lips and gums)
  • fast heartbeat
  • swelling of the face
  • faintness
  • rash
  • hives

Because CINRYZE is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

The most common side effects seen with CINRYZE were headache, nausea, rash, and vomiting. These are not all the possible side effects of CINRYZE. Tell your healthcare provider about any side effect that bothers you or that does not go away. You can also report side effects to ViroPharma Medical Information at (866) 331-5637 or the FDA at 1-800-FDA-1088.

Medicines are sometimes prescribed for purposes other than those listed here. Do not use CINRYZE for a condition for which it is not prescribed. Do not share CINRYZE with other people, even if they have the same symptoms that you have.

Before starting CINRYZE, please read the accompanying Patient Information carefully and each time you get a refill. This information does not take the place of talking with your healthcare provider, and it does not include all of the important information about CINRYZE. If you have questions after reading this, ask your healthcare provider.

Please see the Full Prescribing Information.

Was this content
 useful to you?



100% of users have found
  this content useful